| Aktier | 651,978 Mrd | — | KO KoAct | 0 | Hälsovård | | 2023-08-03 | 24 121,81 | 8,97 | 37,04 |
KO | Aktier | 308,329 Mrd | — | KO KODEX | 0,45 | Hälsovård | FnGuide Bio Index - Benchmark TR Gross | 2016-05-13 | 13 361,03 | 6,85 | 37,93 |
TE | Aktier | 284,006 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KRX Bio K-New Deal Index - KRW - Benchmark TR Gross | 2020-10-06 | 8 365,47 | 4,73 | 58,48 |
TE | Aktier | 210,37 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KRX Healthcare - KRW | 2011-07-15 | 50 939,54 | 5,29 | 44,16 |
TE | Aktier | 102,134 Mrd | — | TE Tiger ETF | 0,30 | Hälsovård | NASDAQ / Biotechnology | 2014-08-26 | 31 029,93 | 4,93 | 21,41 |
KO | Aktier | 96,693 Mrd | — | KO KODEX | 0,09 | Hälsovård | KRX Healthcare - KRW | 2017-03-28 | 23 026,18 | 5,30 | 44,17 |
TE | Aktier | 91,403 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KOSDAQ 150 Biotech Index - KRW - Benchmark TR Gross | 2016-12-14 | 20 615,98 | 11,86 | 59,10 |
| Aktier | 82,665 Mrd | — | KR KB RISE | 0 | Hälsovård | KRX Bio Top 10 Index - KRW - Benchmark TR Gross | 2024-12-24 | 18 228,98 | 9,56 | 68,04 |
TE | Aktier | 63,216 Mrd | — | TE Tiger ETF | 0,49 | Hälsovård | Solactive China Biotech Index | 2020-12-03 | 8 395,74 | 4,06 | 36,34 |
KO | Aktier | 63,055 Mrd | — | KO KODEX | 0,25 | Hälsovård | S&P Health Care Select Sector | 2023-03-21 | 13 501,85 | 4,99 | 23,29 |
TE | Aktier | 45,653 Mrd | — | TE Tiger ETF | 0,45 | Hälsovård | Indxx Global Obesity Treatment Top 2 Plus index - KRW - Benchmark Price Return | 2024-02-29 | 9 975,96 | 9,42 | 20,09 |
KO | Aktier | 43,772 Mrd | — | KO KODEX | 0,45 | Hälsovård | iSelect Global Obesity Treatment TOP2 Plus Index - KRW - Benchmark TR Net | 2024-02-14 | 10 533,34 | 5,31 | 13,57 |
SP | Aktier | 39,243 Mrd | 14,225 M | SP SPDR | 0,08 | Hälsovård | S&P Health Care Select Sector | 1998-12-16 | 147,19 | 4,92 | 22,89 |
TE | Aktier | 33,19 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | KOSPI 200 Health Care Index - KRW | 2015-09-23 | 21 902,59 | 3,35 | 37,49 |
TE | Aktier | 31,242 Mrd | — | TE Tiger ETF | 0 | Hälsovård | S&P Global 1200 Health Care Custom Index - krw - Benchmark TR Gross | 2016-06-29 | 25 575,73 | 0 | 0 |
| Aktier | 28,17 Mrd | — | HW Hwabao | 0,60 | Hälsovård | CSI Medical Index Yield - Benchmark TR Gross | 2019-05-20 | 0,33 | 3,08 | 30,88 |
KO | Aktier | 20,013 Mrd | — | KO KODEX | 0,25 | Hälsovård | S&P Biotechnology Select Industry | 2013-10-31 | 39 347,54 | 0 | 0 |
EF | Aktier | 17,607 Mrd | — | EF E Fund | 0 | Hälsovård | CSI 300 Medical and Health Index - CNY - Benchmark TR Gross | 2021-01-09 | 0,36 | 3,40 | 26,67 |
NH | Aktier | 17,522 Mrd | — | NH NH-Amundi | 0 | Hälsovård | | 2024-11-26 | 16 939,32 | 5,97 | 44,18 |
VA | Aktier | 16,498 Mrd | 231 887,9 | VA Vanguard | 0,09 | Hälsovård | MSCI US IMI 25/50 Health Care | 2004-01-26 | 272,55 | 5,01 | 23,09 |
| Aktier | 14,233 Mrd | — | KO KoAct | 0,50 | Hälsovård | | 2025-11-11 | 10 071,38 | 5,53 | 23,13 |
| Aktier | 12,08 Mrd | — | KR KB RISE | 0 | Hälsovård | FnGuide HealthCare Index - KRW - Benchmark TR Net | 2016-09-23 | 18 201,96 | 5,39 | 38,07 |
KI | Aktier | 9,316 Mrd | — | KI Kiwoom | 0,49 | Hälsovård | FnGuide Medical AI Index - KRW - Benchmark TR Gross | 2024-05-28 | 14 351,49 | 0 | 0 |
| Aktier | 8,879 Mrd | — | AC ACE | 0,30 | Hälsovård | Solactive Global Big Pharma Index - Benchmark Price Return | 2024-11-19 | 12 647,46 | 7,39 | 22,27 |
KO | Aktier | 8,699 Mrd | — | KO KODEX | 0 | Hälsovård | | 2026-01-27 | 9 433,95 | 4,22 | 29,48 |
| Aktier | 8,426 Mrd | — | AC ACE | 0,45 | Hälsovård | Solactive Eli Lilly Value Chain Index - Benchmark Price Return | 2024-11-19 | 11 981,39 | 3,59 | 23,17 |
IS | Aktier | 8,048 Mrd | 1,833 M | IS iShares | 0,44 | Hälsovård | NYSE Biotechnology (TR) | 2001-02-05 | 163,82 | 5,09 | 21,95 |
SP | Aktier | 7,895 Mrd | 9,071 M | SP SPDR | 0,35 | Hälsovård | S&P Biotechnology Select Industry | 2006-01-31 | 121,11 | 4,82 | 0 |
TE | Aktier | 7,089 Mrd | — | TE Tiger ETF | 0,50 | Hälsovård | FnGuide Medical Device Index - KRX - Benchmark TR Net | 2018-11-07 | 19 854,11 | 2,90 | 23,45 |
BO | Aktier | 6,371 Mrd | — | BO Bosera | 0,65 | Hälsovård | Hang Seng Healthcare Index - CNY - Benchmark TR Gross | 2021-03-18 | 0,57 | 2,75 | 12,80 |
CH | Aktier | 6,166 Mrd | — | CH ChinaAMC | 0,65 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-09-29 | 0,75 | 3,00 | 21,32 |
| Aktier | 6,063 Mrd | — | MA Maxwealth | 0,60 | Hälsovård | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 2021-04-22 | 0,49 | 2,64 | 31,06 |
KI | Aktier | 5,711 Mrd | — | KI Kiwoom | 0,49 | Hälsovård | Solactive Blockbuster Biotech Drugs Index - CNY - Benchmark TR Net | 2024-05-28 | 11 418,81 | 4,40 | 17,99 |
| Aktier | 5,51 Mrd | — | KO KoAct | 0,50 | Hälsovård | | 2024-09-03 | 12 147,89 | 4,05 | 18,25 |
| Aktier | 5,441 Mrd | — | NI Nippon | 0,19 | Hälsovård | Nifty Pharma Index - INR - Benchmark TR Gross | 2021-07-02 | 17,49 | 4,59 | 31,47 |
NF | Aktier | 5,258 Mrd | — | NF NEXT FUNDS | 0,32 | Hälsovård | | 2008-03-21 | 32 540,42 | 1,85 | 20,34 |
| Aktier | 5,192 Mrd | — | KR KB RISE | 0,35 | Hälsovård | KEDI Global Obesity Care Industry Top2+ Index - KRW - Benchmark TR Net | 2024-02-27 | 9 393,69 | 8,01 | 19,48 |
TE | Aktier | 4,915 Mrd | — | TE Tiger ETF | 0,40 | Hälsovård | TOPIX-17 PHARMACEUTICAL - JPY | 2016-06-29 | 12 065,00 | 0 | 0 |
IC | Aktier | 4,753 Mrd | — | IC ICBC | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-03-26 | 1,25 | 0 | 0 |
IN | Aktier | 4,142 Mrd | — | IN Invesco | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2024-10-16 | 1,52 | 3,45 | 24,62 |
EF | Aktier | 4,018 Mrd | — | EF E Fund | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-03-18 | 1,18 | 0 | 0 |
GU | Aktier | 3,769 Mrd | — | GU Guotai | 0,60 | Hälsovård | CSI Biomedical Index - CNY - Benchmark TR Gross | 2019-04-18 | 0,95 | 0 | 0 |
IS | Aktier | 3,726 Mrd | 295 900,4 | IS iShares | 0,40 | Hälsovård | S&P Global 1200 / Health Care -SEC | 2001-11-13 | 92,88 | 4,33 | 21,87 |
IS | Aktier | 3,363 Mrd | 2,188 M | IS iShares | 0,38 | Hälsovård | DJ US Select / Medical Equipment | 2006-05-01 | 55,13 | 3,84 | 30,11 |
XT | Aktier | 3,336 Mrd | — | XT Xtrackers | 0,25 | Hälsovård | MSCI World Index / Health Care -SEC | 2010-11-22 | 55,78 | 4,49 | 22,03 |
FU | Aktier | 3,054 Mrd | — | FU Fullgoal | 0,60 | Hälsovård | Hang Seng Hong Kong Stock Connect Healthcare Index - CNY - Chinese Renminbi - Benchmark TR Gross | 2023-06-14 | 1,29 | 0 | 0 |
IS | Aktier | 2,943 Mrd | 824 405,4 | IS iShares | 0,38 | Hälsovård | Russell 1000 Health Care RIC 22.5/45 Capped Index | 2000-06-12 | 61,38 | 4,92 | 23,03 |
FI | Aktier | 2,847 Mrd | 188 955,6 | FI Fidelity | 0,08 | Hälsovård | MSCI US IMI 25/50 Health Care | 2013-10-21 | 70,38 | 4,81 | 22,89 |
NH | Aktier | 2,735 Mrd | — | NH NH-Amundi | 0,45 | Hälsovård | iSelect K-MediTech Index - KRW - Benchmark Price Return | 2023-12-21 | 9 115,65 | 3,43 | 26,31 |
IS | Aktier | 2,595 Mrd | — | IS iShares | 0,15 | Hälsovård | S&P 500 CAPPED 35/20 HEALTH CARE NTR | 2015-11-20 | 11,78 | 5,01 | 23,30 |
GU | Aktier | 2,351 Mrd | — | GU Guotai | 0,60 | Hälsovård | CSI Medical Index Yield - Benchmark TR Gross | 2020-12-24 | 0,41 | 3,08 | 30,90 |
| Aktier | 2,257 Mrd | — | HW Hwabao | 0 | Hälsovård | Hang Seng SCHK Innovative Drug Select Index - HKD - Benchmark TR Gross | — | 4,67 Mrd | 0 | 0 |
FT | Aktier | 2,229 Mrd | 146 718,5 | FT First Trust | 0,54 | Hälsovård | NYSE Arca Biotechnology Index | 2006-06-19 | 192,42 | 3,25 | 21,80 |
CH | Aktier | 2,13 Mrd | — | CH ChinaAMC | 0,75 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-03-18 | 14,15 | 3,49 | 28,07 |
CH | Aktier | 2,13 Mrd | — | CH ChinaAMC | 0,75 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-03-18 | 14,15 | 3,49 | 28,07 |
PA | Aktier | 1,836 Mrd | — | PA Ping An | 0,60 | Hälsovård | CSI Pharmaceutical and Medical Device Innovation Index - CNY - Benchmark TR Gross | 2021-06-09 | 0,35 | 4,13 | 25,07 |
HE | Aktier | 1,611 Mrd | — | HE Harvest ETFs | 1,06 | Hälsovård | | 2014-11-19 | 7,10 | 5,01 | 23,83 |
EF | Aktier | 1,504 Mrd | — | EF E Fund | 0,20 | Hälsovård | Yield of China Securities Hong Kong Stock Connect Medical and Health Composite Index - CNY - Benchmark TR Net | 2022-01-19 | 1,02 | 2,50 | 20,25 |
AM | Aktier | 1,49 Mrd | — | AM Amundi | 0,50 | Hälsovård | MSCI World IMI Virology Select Index - KRW - Benchmark TR Net | 2022-06-08 | 9 937,75 | 2,82 | 14,76 |
IS | Aktier | 1,462 Mrd | — | IS iShares | 0,18 | Hälsovård | MSCI Europe Health Care 20/35 Capped Index - EUR | 2020-11-17 | 6,88 | 3,81 | 19,87 |
EF | Aktier | 1,418 Mrd | — | EF E Fund | 0,20 | Hälsovård | China Securities Medical Index - CNY - Benchmark TR Gross | 2021-07-08 | 0,39 | 4,40 | 29,55 |
EF | Aktier | 1,418 Mrd | — | EF E Fund | 0,20 | Hälsovård | CSI Biotechnology Theme Index - CNY - Benchmark TR Gross | 2021-01-14 | 0,47 | 2,80 | 29,20 |
CA | Aktier | 1,388 Mrd | — | CA Cathay | 1,05 | Hälsovård | Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net | 2021-11-22 | 7,98 | 3,49 | 18,53 |
IS | Aktier | 1,308 Mrd | — | IS iShares | 0,46 | Hälsovård | S&P Global 1200 Healthcare Sector Index - AUD | 2001-11-13 | 129,11 | 0 | 0 |
VA | Aktier | 1,307 Mrd | 377 540,1 | VA VanEck | 0,36 | Hälsovård | MVIS US Listed Pharmaceutical 25 | 2011-12-20 | 102,24 | 5,01 | 18,89 |
GU | Aktier | 1,295 Mrd | — | GU Guotai | 0,60 | Hälsovård | SSE STAR Market Innovative Drug Index - CNY - Benchmark TR Gross | 2025-08-01 | 0,84 | 0 | 0 |
EF | Aktier | 1,226 Mrd | — | EF E Fund | 0,20 | Hälsovård | CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross | 2021-02-03 | 0,63 | 3,14 | 28,62 |
XT | Aktier | 1,13 Mrd | — | XT Xtrackers | 0,12 | Hälsovård | MSCI USA / Health Care -SEC | 2017-09-12 | 59,11 | 5,21 | 23,49 |
XT | Aktier | 1,13 Mrd | — | XT Xtrackers | 0,12 | Hälsovård | MSCI USA / Health Care -SEC | 2017-09-12 | 59,11 | 5,21 | 23,49 |
HA | Aktier | 1,041 Mrd | — | HA Harvest | 0,60 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2025-07-30 | 0,82 | 0 | 0 |
IS | Aktier | 1,01 Mrd | — | IS iShares | 0,40 | Hälsovård | STOXX Global Breakthrough Healthcare (USD)(NR) | 2016-09-08 | 8,61 | 3,83 | 20,88 |
IS | Aktier | 994,106 M | — | IS iShares | 0,40 | Hälsovård | STOXX Global Breakthrough Healthcare (USD)(NR) | 2016-09-08 | 8,48 | 3,83 | 20,88 |
IS | Aktier | 989,832 M | 82 306,48 | IS iShares | 0,38 | Hälsovård | DJ US Select / Pharmaceutical | 2006-05-01 | 85,08 | 4,64 | 21,28 |
GX | Aktier | 965,57 M | — | GX Global X | 0,59 | Hälsovård | FactSet Japan Bio & Med Technologies Index - JPY - Benchmark TR Net | 2021-06-21 | 1 665,83 | 2,02 | 19,51 |
IS | Aktier | 891,37 M | — | IS iShares | 0,35 | Hälsovård | NASDAQ / Biotechnology | 2017-10-19 | 8,25 | 0 | 0 |
CS | Aktier | 856,997 M | — | CS CSOP | 1,50 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Net | 2021-07-21 | 3,41 | 3,42 | 26,68 |
FT | Aktier | 856,286 M | 27 126,73 | FT First Trust | 0,61 | Hälsovård | StrataQuant Health Care Index | 2007-05-08 | 107,36 | 2,95 | 17,04 |
AM | Aktier | 817,302 M | — | AM Amundi | 0,30 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2019-01-17 | 146,14 | 3,02 | 20,55 |
AM | Aktier | 817,302 M | — | AM Amundi | 0,30 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2019-01-17 | 146,14 | 3,02 | 20,55 |
| Aktier | 800,027 M | — | WA Wanjia | 0 | Hälsovård | CSI Hong Kong Stock Connect Innovative Drug Index - CNY - Benchmark TR Net | 2024-09-13 | 1,46 | 3,45 | 24,62 |
CA | Aktier | 722,821 M | — | CA Cathay | 0,41 | Hälsovård | Bloomberg Barclays 15+ Year Healthcare Select Index - Benchmark TR Net | 2019-04-23 | 30,38 | 0 | 0 |
IN | Aktier | 717,884 M | 88 714,95 | IN Invesco | 0,40 | Hälsovård | S&P 500 Equal Weighted / Health Care -SEC | 2006-11-01 | 30,45 | 3,11 | 19,88 |
| Aktier | 704,19 M | 99 185,66 | PB Portfolio Building Block | 0,13 | Hälsovård | BITA Global Pharma and Biotech Select Index - Benchmark TR Net | 2025-11-24 | 25,02 | 5,27 | 20,40 |
AM | Aktier | 700,759 M | — | AM Amundi | 0,30 | Hälsovård | MSCI World Index / Health Care -SEC | 2010-08-19 | 462,47 | 7,68 | 29,88 |
IS | Aktier | 700,447 M | — | IS iShares | 0,46 | Hälsovård | STOXX Europe 600 / Health Care (Capped) - SS | 2001-04-25 | 109,82 | 3,63 | 19,37 |
IS | Aktier | 698,319 M | 271 605,5 | IS iShares | 0,38 | Hälsovård | DJ US Select / Health Care Providers | 2006-05-01 | 43,25 | 2,20 | 16,35 |
GX | Aktier | 627,78 M | — | GX Global X | 0,68 | Hälsovård | Solactive China Biotech Index | 2019-07-25 | 66,78 | 4,31 | 40,01 |
GX | Aktier | 627,724 M | — | GX Global X | 0,68 | Hälsovård | Solactive China Biotech Index | 2019-07-25 | 66,77 | 4,31 | 40,01 |
SP | Aktier | 620,006 M | — | SP SPDR | 0,30 | Hälsovård | MSCI World Health Care 35/20 Capped Index - Benchmark TR Net | 2016-04-29 | 64,40 | 5,08 | 25,68 |
CS | Aktier | 591,492 M | — | CS China Southern | 0,65 | Hälsovård | Hang Seng Biotech Index - HKD - Benchmark TR Gross | 2022-06-17 | 1,06 | 2,98 | 21,35 |
IS | Aktier | 588,191 M | — | IS iShares | 0,18 | Hälsovård | MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped Index - Benchmark TR Net | 2019-10-17 | 7,38 | 4,16 | 22,04 |
SP | Aktier | 575,183 M | — | SP SPDR | 0,18 | Hälsovård | MSCI Europe Health Care Index - EUR | 2014-12-05 | 218,51 | 3,81 | 19,87 |
SP | Aktier | 551,981 M | — | SP SPDR | 0,15 | Hälsovård | S&P Health Care Select Sector Daily Capped 25/20 Index | 2015-07-07 | 45,45 | 4,92 | 22,89 |
FU | Aktier | 524,893 M | — | FU Fullgoal | 0,60 | Hälsovård | CSI Pharmaceutical 50 Index - CNY - Benchmark TR Gross | 2020-03-16 | 0,91 | 0 | 0 |
CH | Aktier | 518,644 M | — | CH ChinaAMC | 0,60 | Hälsovård | CSI All-Medical Device Index - CNY - Benchmark TR Gross | 2023-11-23 | 0,86 | 2,64 | 31,04 |
IS | Aktier | 512,011 M | — | IS iShares | 0,66 | Hälsovård | S&P Global 1200 Health Care Hedged to CAD Index - CAD | 2011-04-12 | 67,03 | 0 | 0 |
DI | Aktier | 508,018 M | 626 389,9 | DI Direxion | 0,96 | Hälsovård | S&P Biotechnology Select Industry | 2015-05-28 | 145,81 | 0 | 0 |
GU | Aktier | 483,964 M | — | GU Guotai | 0,60 | Hälsovård | CSI Shanghai-Hong Kong-Shenzhen Innovative Pharmaceutical Industry Index - CNY - Benchmark TR Gross | 2021-09-08 | 0,69 | 3,53 | 27,58 |
IN | Aktier | 419,02 M | — | IN Invesco | 0,40 | Hälsovård | NASDAQ / Biotechnology | 2014-11-06 | 58,93 | 5,11 | 22,17 |
CS | Aktier | 403,074 M | — | CS China Southern | 0,20 | Hälsovård | CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross | 2021-03-12 | 0,63 | 3,14 | 28,61 |